Latest Financial Results
Q3 2022
Latest Annual Report
For Fiscal Year Ending Dec 31, 2021
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company that applies its technology to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis' proven technology drives improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics.
IR Contacts
Headquarters
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
United States
T: (650) 421-8100
media@codexis.com
Investor Relations
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
T: 650-421-8106
ir@codexis.com
Transfer Agent
EQ Shareowner Services
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120-4100
T: 800-468-9716
https://www.shareowneronline.com